INT250253
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Our immunohistochemical analysis of nonpathologic human CNS tissue (both cortical and spinal cord) reveal that EAAT2, but not EAAT1, normally colocalizes with AQP4 in gray matter astrocytes (Fig. 5 A) and that EAAT2 is most enriched in spinal cord gray matter (Fig. 5 B, top). | |||||||||||||||
| |||||||||||||||
|
These results imply a specific association between AQP4 and EAAT2 that does not exist for EAAT1. | |||||||||||||||
| |||||||||||||||
|
The reduction in astrocytic glutamate transport accompanying AQP4 down-regulation after exposure to NMO-IgG further supports our suggestion that AQP4 and EAAT2 are associated functionally in the plasma membrane.
| |||||||||||||||
| |||||||||||||||
|
However, our demonstration that the major astrocytic glutamate transporter EAAT2 exists in a macromolecular complex with the AQP4 water channel, and is down-regulated by AQP4-specific autoantibodies that are restricted to patients with the NMO-spectrum of CNS inflammatory autoimmune demyelinating disorders, has unanticipated pathogenic implications for glutamate toxicity as a central mechanism in a spectrum of disorders that are commonly mistaken for MS. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.